Biotechnology News

January 3, 2013

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application 12/823,007, titled “Heterocyclic Compounds for the...

January 3, 2013

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today announced positive topline results from a phase 1 study of its new antipsychotic candidate, ALKS 3831, a combination of a proprietary drug molecule, ALKS 33, and olanzapine, a molecule...

January 3, 2013

HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm announced that President and Chief Executive Officer, Igor Gonda, will present at Biotech Showcase 2013 on Wed, January 9, 2013, at 11 a.m. PT.

January 3, 2013

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Biotech ShowcaseTM 2013 Conference

January 3, 2013

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Ophthotech to Present at 31st Annual J.P. Morgan Healthcare Conference

January 3, 2013

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (Nasdaq:AFFX) today announced that it will webcast the Company’s presentation at the 31st Annual JP Morgan Healthcare Conference in San Francisco, California on Thursday, January 10, 2013....

January 3, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today congratulates Robert S. Langer, ScD,...

January 3, 2013

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Tau Therapeutics completed a normal healthy volunteer dose escalation trial of its T-type calcium channel inhibitor mibefradil to evaluate PK and confirm safe dose levels for a Phase 1b cancer trial.

January 3, 2013

LONDON--(BUSINESS WIRE)--New market research report on the European Infectious Disease Testing Market worked out by Venture Planning Group has been recently published at MarketPublishers.com

January 3, 2013

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Paris:IPN) (Euronext: IPN; ADR: IPSEY) announced today its corporate agenda* for 2013: 30 January 2013:       Full year 2012 sales 27 February 2013: Full year 2012 results 25 April 2013: First...

January 3, 2013

HOOFDDORP, The Netherlands--(BUSINESS WIRE)--Bioventus, a global leader in active orthopaedic healing, expanded its European footprint today by officially launching its company and products in Italy. The company, which opened its International...

January 3, 2013

TAIPEI, Taiwan--(BUSINESS WIRE)--PharmaEngine, Inc. (TWO: 4162) announced today the execution of a Collaboration and Research Agreement with Guangzhou BeBetter Medicine Technology Co., Ltd. (BeBetter). The two companies will collaborate to design...

January 2, 2013

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero...

January 2, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 31st Annual J.P. Morgan Healthcare Conference on...

January 2, 2013

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Relypsa announced Special Protocol Assessment (SPA) agreement with the US Food and Drug Administration for Phase 3 trial evaluating for efficacy and safety of patiromer for treatment of hyperkalemia

January 2, 2013

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Relypsa, Inc., announced today the recent appointments to serve on the company’s board of directors: Paul J. Hastings, President and CEO of OncoMed and David W.J. McGirr, SVP and CFO of Cubist.

January 2, 2013

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has acknowledged the resubmission of a New Drug Application (NDA)...

January 2, 2013

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the J. P. Morgan Healthcare Conference being...

January 2, 2013

WASHINGTON--(BUSINESS WIRE)--BIO thanks Congress for extending the cellulosic biofuel production and bonus depreciation tax credits and for allowing algae biofuels to qualify in the fiscal cliff bill.

January 2, 2013

BOULDER, Colo.--(BUSINESS WIRE)--Clovis CEO to present at JP Morgan Healthcare Conference

January 2, 2013

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec to Present at the 31st Annual J.P. Morgan Conference on January 7th, 2013

January 2, 2013

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today that President and Chief Executive Officer Robert Vaters will present at the 31st Annual J.P. Morgan Healthcare Conference on Wednesday,...

January 2, 2013

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the 31st Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 8, 2013, at 8:00 a.m. PST (11:00 a.m. EST/4:00 p.m....

January 2, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the 31st Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2013 at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time at...

January 2, 2013

ST. LOUIS, TORONTO & BOSTON--(BUSINESS WIRE)--C2N Diagnostics, InterVivo Solutions, and inviCRO (“Companies”) today announced the formation of a pre-competitive consortium to develop, standardize, and validate an aged-canine model of...

January 2, 2013

REDWOOD CITY, Calif.--(BUSINESS WIRE)--OncoMed Pharmaceuticals, a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today announced that the U.S. Food and Drug Administration (...

January 2, 2013

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that Jon Stonehouse, President and Chief Executive Officer of BioCryst is scheduled to present and provide a corporate summary and update...

January 2, 2013

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological...

January 2, 2013

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals Announces Presentation at the 2013 Biotech Showcase™ Conference on January 7 in San Fransciso: CEO Dr. Mark Pykett to Provide Business and Development Program Updates

January 2, 2013

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at the JP Morgan 31st Annual Healthcare Conference in San...

January 2, 2013

SAN RAMON, Calif.--(BUSINESS WIRE)--BioVentrix appoints industry veteran Noel Messenger as Vice President of Regulatory & Clinical Affairs

January 2, 2013

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) announced that its C1™ Single-Cell Auto Prep system Early Access Program (EAP) has concluded.

January 2, 2013

PORTLAND, Ore.--(BUSINESS WIRE)--CytoDyn announced that it has entered into a consulting agreement with former U.S. Ambassador Sam Zakhem. Mr. Zakhem will assist the Company in developing business relationships in the Middle East.

January 2, 2013

LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced the appointment of Greg Madison as executive vice president and chief commercial officer. Mr. Madison brings a wealth of hands-on commercial experience...

January 2, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScienceSM, (OTC: OVSC), a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, announced today the appointment of Alison Lawton to Chief...

January 2, 2013

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, announced that President and CEO Steven A. Kriegsman and Vice President, Business Development David J....

January 2, 2013

LOS ANGELES--(BUSINESS WIRE)--The Gores Group, a global investment firm focused on acquiring controlling interests in mature and growing businesses, today announced that it has completed the acquisition of Therakos, Inc. from Ortho-Clinical...

January 2, 2013

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) approved ELIQUIS® (apixaban) to reduce the risk of stroke and...

January 2, 2013

EMERYVILLE, Calif.--(BUSINESS WIRE)--Human Genome Interpretation Company Omicia Appoints Mike Aicher as CEO

January 2, 2013

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will present at the 31st Annual J.P. Morgan Healthcare Conference on Monday, January 7, at 3:00 p.m. Pacific Standard Time. The conference...

January 2, 2013

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) will host a conference call to discuss its commercialization plan for Gattex, including the cost of therapy, today at 5:00 p.m. Eastern Time. To participate in the...

January 2, 2013

LAKE FOREST, Calif.--(BUSINESS WIRE)--Cryoport, Inc. (OTCBB:CYRX) today announced that Chief Executive Officer Jerrell Shelton is scheduled to present at the Biotech Showcase on Monday, January 7, 2013 at 9:00 a.m. Pacific time. The conference is...

January 2, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the 31st Annual J.P. Morgan Healthcare Conference being held in San Francisco. Harvey J. Berger, M.D., chairman and chief...

January 2, 2013

RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Food and Drug Administration has approved Fulyzaq™ (crofelemer) 125 mg delayed-release tablets for the symptomatic relief of non-infectious...

January 2, 2013

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) today announced that the European Commission granted orphan medicinal product designation to Emergent’s humanized single chain monoclonal antibody against CD37, also called...

January 2, 2013

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals will present overview of the Company's business strategy and commercial and development-stage programs at the 31st Annual J.P. Morgan Healthcare Conference.

January 2, 2013

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (NASDAQ: BRKR) announced today that it will present at the 31st J.P. Morgan Healthcare Conference on Monday, January 7, 2013, at 11:30 a.m. Pacific Time at the Westin St. Francis Hotel in San...